Abstract
Until recently hydrogen sulfide (H2S) was the least appreciated of the three gasotransmitters but now recognized as 3rd gaseous mediator after nitric oxide(NO) and carbon monoxide (CO). H2S regulates a number of physiological processes like vasorelaxation. prevention of inflammation, leukocyte adhesion, anti-proliferative effects, anti-thrombotic effects, resistance to oxidative stress and protection against ischemia reperfusion injury (IRI. However, considerable amount of research is still needed to evaluate the mechanisms involved in the therapeutic effects of H2S in IRI such as its effects on nuclear factor-kappa B (NF-kappa B) concentration and intercellular adhesion molecule-I (ICAM-I) expression in renal IRI and ARF (acute renal failure). More than a decade of good repute among researchers. H2S research has certain results that need to be clarified more such as whether H2S is pro-inflammatory or anti-inflammatory agent. Moreover. pathways adopted by H2S in the protein modification and its effects on cell signalling specially its effect on NF-kappa B in the process of inflammation are not fully elucidated. H2S has delighted researchers and a great deal of information is being generated every year. The main purpose of the review is to provide an update on the development in the research of H,S in renal IRI due to uncertainty of the exact role of H2S on ICAM-I expression and NF-kappa B concentration whether it inhibits or activates them.